These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29214668)

  • 1. Photofrin
    Baran TM
    Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
    Xiao Z; Brown K; Tulip J; Moore RB
    J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porfimer Sodium Versus PS785 for Photodynamic Therapy (PDT) of Lung Cancer Xenografts in Mice.
    Nwogu C; Kloc A; Attwood K; Bshara W; Durrani F; Pandey R
    J Surg Res; 2021 Jul; 263():245-250. PubMed ID: 33713956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.
    Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG
    J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
    Li LB; Luo RC
    Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor delivery of Photofrin® by PLL-g-PEG for photodynamic therapy.
    Kano A; Taniwaki Y; Nakamura I; Shimada N; Moriyama K; Maruyama A
    J Control Release; 2013 May; 167(3):315-21. PubMed ID: 23454112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.
    Igarashi A; Konno H; Tanaka T; Nakamura S; Sadzuka Y; Hirano T; Fujise Y
    Toxicol Lett; 2003 Nov; 145(2):133-41. PubMed ID: 14581165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
    Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
    Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irradiance, Photofrin
    Oakley E; Bellnier D; Hutson A; Cooper H; Habitzruther M; Sexton S; Curtin L; Tworek L; Mallory M; Henderson B; Shafirstein G
    Photochem Photobiol; 2020 Mar; 96(2):397-404. PubMed ID: 31887227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
    Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
    Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
    Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
    van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
    Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
    Morrison SA; Hill SL; Rogers GS; Graham RA
    J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
    Sitnik TM; Henderson BW
    Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
    Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
    Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.
    Anderson C; Hrabovsky S; McKinley Y; Tubesing K; Tang HP; Dunbar R; Mukhtar H; Elmets CA
    Photochem Photobiol; 1997 May; 65(5):895-901. PubMed ID: 9155263
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Penjweini R; Kim MM; Ong YH; Zhu TC
    Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of murine skin tumors using Photofrin-II.
    Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.